FDA Inspection 1133259 — Edward M. Kerwin, M.D
The FDA completed an inspection of Edward M. Kerwin, M.D on November 13, 2020 in Medford, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 13, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Medford, OR (United States)
Additional Details
Clinical Investigator (CI)